- Medtech expert to drive commercialization of BioHealx ® for the treatment of anal fistula. GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology ...
Pivotal data supports U.S. FDA De Novo clearance and sets the stage for U.S. launch GALWAY, Ireland--(BUSINESS WIRE)-- Signum Surgical, a medical technology company dedicated to advancing the ...
The U.S. FDA granted Signum Surgical Ltd. de novo marketing clearance for its Biohealx technology as a treatment for anal fistula. Biohealx is a single use, bioabsorbable implant, designed to not only ...
St. David's testing a wrap that could help dialysis patients maintain vein access and avoid repeat surgeries by rerouting ...
A consortium of Birmingham researchers, clinicians and industry partners has received a second £1.1m award from the National Institute for Health and Care Research (NIHR) for a three-year study ...
Northwell's Staten Island University Hospital (SIUH) is the first medical center in the United States to perform surgery using the newly FDA-cleared BioHealx (R)Anal Fistula Device - offering new hope ...
An anal fistula is a tunnel that develops from the inside of the anus to the skin outside. It usually starts near blocked or infected anal glands and forms an abscess (a pus-filled pocket). Pus and ...
An AV fistula may fail for various reasons, including low or poor blood flow, failure to mature, excessive pain, a sclerotic vein, and a thrombotic vein. Failure can be disheartening to a patient who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results